EARLY TOXICITY OF SCHEDULED HODGKIN LYMPHOMA IN CHILDREN
https://doi.org/10.21518/2079-701X-2017-6-160-165
Abstract
Given the high number of patient survival rates with Hodgkin lymphoma (HL), most modern studies are focused on strategies to reduce the toxicity of treatment. The objectives of this study were to assess the early toxicity of the protocols DAL-HD (German working group for study and treatment of leukaemia in children) and SPbLH (St. Petersburg group on treatment of Hodgkin Lymphoma in children) compatible by effectiveness used in therapy of HL in children and adolescents. The study includes 143 HL patients aged between 3 and 18 (median-11.6 years), who received treatment from 1993 to 2015 under the following programs: DAL-HD-versions 87 and 90 and original research protocol SPBLH-05. Analysis of the direct toxicity of polychemotherapy (PCT) showed that the therapy according to DAL-HD protocol has a more pronounced emetogenicity and myelotoxicity than the SPbLH protocol. The most pronounced complications of PCT have been recorded in high-risk patients treated by DAL-HD program (hematotoxicity degree 3-4, dyspeptic syndrome with hypotrophy development). By reducing the combined doses of anthracycline antibiotics and alkylating agents, therapy by SPbLH protocol is accompanied by less pronounced side effects while maintaining a high level of common and relapsed survival. Thus, risk-adapted SPbLH programme can be recommended for the treatment of children and adolescents suffering from HL.
About the Author
D. A. ZVYAGINTSEVA
Petrov Scientific and Research Institute of Oncology of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Кулева С., Анишкин М., Колыгин Б. Лимфома Ходжкина у детей и подростков: эффективность риск-адаптированного протокола СПбЛХ-05. Детская онкология, 2007, 3(4): 16-20.
2. Феоктистов Р., Щурова О., Абугова Ю. Кардиотоксичность химиолучевой терапии лимфомы Ходжкина у детей и подростков. Современные технологии в диагностике и лечении, 2011, 2: 15-20.
3. Girinsky T, M`Kacher R, Lessard N. Prospective coronary heart disease screening in asymptomatic H.L. patients using coronary computed tomography angiography: results and risk factors analysis. Int. J. Radiat Oncology BidPhys, 2014, 89(1): 59-66.
4. Колыгин Б., Кулева С. Диагностика и лечение лимфомы Ходжкина. Гиппократ, 2009, 208 с.
5. Guermazi A, Brice P, de Kerviler E et al. Extranodal Hodgkin disease: spectrum of disease. Radiographics, 2001, 21(1): 161-79.
6. Kumar A, Burger I, Zhang Z et al. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes. Haematologica, 2016, 101(10): 1237-1243.
7. Cheson B, Fisher R, Barrington S. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol, 2014, 32(27): 3059–068.
Review
For citations:
ZVYAGINTSEVA DA. EARLY TOXICITY OF SCHEDULED HODGKIN LYMPHOMA IN CHILDREN. Meditsinskiy sovet = Medical Council. 2017;(6):160-165. (In Russ.) https://doi.org/10.21518/2079-701X-2017-6-160-165
Views:
555
Email this article 